Investor directoryLongGame
LongGame focuses exclusively on radical lifespan extension technologies that aim to slow or reverse aging.
The facts
- Typical cheque
- €100k – €10M
- Headquarters
- London, United Kingdom
- Founded
- 2024
Selected portfolio
Enhanced Games (NYS: ENHA)Oisin BiotechnologiesR3 Bio (Drug Delivery)Deciduous TherapeuticsVincere BiosciencesImmuneBridgeRevel PharmaceuticalsRenewalBioTelos BiotechRepair BiotechnologiesTotality BiosciencesRevel PharmaSyntax BioHerasightEnhanced GamesAperture TherapeuticsRenewal BioImmune BridgeGeneral ProximityDeciduousOisin BioVincere BioAdaptyv BioLucis Life
and 3 more
Questions founders ask
- How much does LongGame typically invest?
- LongGame states a typical cheque of €100k – €10M.
- Which stages does LongGame invest in?
- LongGame invests at Pre-Seed, Seed and Series A.
- Where is LongGame based?
- LongGame is headquartered in London, United Kingdom.
Search investors like this in Claude — no account, no sign-in. Open in Claude
Are you LongGame? Tell us what to correct and we will update it — or ask us to remove the entry.